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Mapping and Ablation of Complex Cardiac Arrhythmia Guided by a
Novel Three-Dimensional Non-Contact Endocardial Activation
Mapping System
WING-HONG FUNG, CHI-KIN CHAN, KAM-SANG WOO, WILSON WAI-MAN CHAN, PINKY NG, LINDA
NG, JOHN E SANDERSON
From Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese
University of Hong Kong, Hong Kong
FUNG ET AL.: Mapping and Ablation of Complex Cardiac Arrhythmia Guided by a Novel Three-Dimensional
Non-Contact Endocardial Activation Mapping System. Conventional cardiac activation mapping requires a
sequentially-based method of positioning a catheter in contact with the endocardium to generate intracardiac
electrograms at single points during sustained arrhythmia. Significant limitation of such point by point mapping
may be encountered when applying to complex arrhythmia e.g. non-sustained arrhythmia or haemodynamically
unstable arrhythmia. A novel non-contact mapping system (Ensite 3000 system) providing a three-dimensional
simultaneous display of arrhythmia activation may offer a solution. The non-contact mapping system consists of a
specially designed balloon catheter (Ensite EP catheter) with 64 insulated wires over the surface of the balloon for
sensing electrical potentials on the endocardium and transmitting the signals to the Patient Interface Unit (PIU) for
processing. It uses proprietary algorithms to reconstruct the three-dimensional cardiac chamber geometry and
global endocardial activation sequences. This non-contact mapping system can provide a navigational guide in
assisting ablation catheter to the target sites of interest. In this article, the mapping and ablation procedures in
patents with (1) focal right atrial tachycardia, (2) haemodynamically unstable right ventricular outflow tract
ventricular tachycardia and (3) symptomatic ventricular ectopics are described. Using this non-contact mapping
system, patients with haemodynamically unstable or symptomatic non-sustained arrhythmia may also be successfully
treated by ablative therapy with shorter procedure and fluoroscopy time. (J HK Coll Cardiol 2001;9:157-165)
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Introduction
Detailed catheter-based mapping of cardiac
chambers is a prerequisite for successful ablation
therapy for cardiac arrhythmia. Current techniques using
catheters with a limited number of recording electrodes
guided by fluoroscopy have significant limitations for
cardiac mapping. It only provides a single-point electrophysiological data under two-dimensional fluoroscopic
display. Point by point contact mapping is required
during sustained arrhythmia to look for earliest site of
activation. The conventional techniques are difficult or
perhaps impossible to map non-sustained or
haemodynamically unstable arrhythmia. The new noncontact mapping system (Ensite 3000 system,
Endocardial Solution Inc) providing a global and
simultaneous view of arrhythmia activation may offer
a solution to the limitations of conventional mapping
techniques.1-6 The Ensite system consists of a 7.5 ml
balloon mounted on a 9 French catheter which is woven
of a braid of 64 insulated 0.003 inch diameter wires.
This non-contact catheter together with a standard
roving catheter are positioned inside the cardiac
chamber. By emitting a high frequency signal from the
roving catheter, distance between the two catheters can
then be calculated. By moving the roving catheters along
the endocardial surface and certain anatomical
landmarks (e.g. tricuspid annulus, His bundle or inferior
vena cava), the geometry of the cardiac chamber can
then be established. As the roving catheter moves along
the endocardial surface, sampling of several reference
intracardiac potential was recorded. These electrical
potentials on the endocardium detected by the roving
catheter together with the anatomical information are
relayed to the Patient Interface Unit (PIU) of the
workstation. This workstation then uses proprietary
algorithms to combine the electrical and anatomical
information of the cardiac chamber of interest. In each
cardiac cycle, endocardial potentials sensed by the noncontact catheter were amplified, filtered and sampled
at 1200 Hz and passed to a high-order boundary-element
computation system. The computation system uses an
inverse formulation to solve Laplace's equation for each
sample, yielding endocardial potentials of the whole
cardiac chamber. The computed electrograms or virtual
electrograms derived by the Ensite system have been
well validated with negligible difference from those of
conventional contact mapping. The potentials are applied
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to spline curve model of the chamber corresponding to
3360 points over the endocardial surface of the cardiac
chamber. The three-dimensional display of the Ensite
system provides both anatomical and electrophysiological
data for activation mapping. The position of the ablation
catheter is marked in this three-dimensional display
map. Therefore this system offers a non-fluoroscopic
navigational guide to the ablation catheters targeting
the sites of interest.
In this article, the application of this novel noncontact mapping system on 3 patients with complex
cardiac arrhythmia was described. This global activation
mapping may allow a better understanding of the critical
elements necessary to initiate and maintain a
tachycardia. Moreover, with the use of this new mapping
system, the indication for therapeutic application of
radiofrequency ablation may be extended to those
patients suffering from haemodynamically unstable or
non-sustained arrhythmia.

Patients
We studied 3 patients with complex cardiac
arrhythmia: (1) focal right atrial tachycardia (AT), (2)
haemodynamically unstable right ventricular outflow
tract (RVOT) ventricular tachycardia (VT) and (3)
symptomatic ventricular ectopics (VE) in arrhythmogenic
right ventricular dysplasia (ARVD).
First patient was a 46-year-old lady presented
with recurrent palpitation for 3 years. Long RP tachycardia
was detected in 24-hour Holter study. On average, she
experienced 2 episodes of palpitation attack per week,
which lasted for 2-3 hours despite 2 different antiarrhythmic drugs. Echocardiographic examination
before electrophysiology study (EPS) showed normal
chamber sizes, heart valves and cardiac function. Second
patient was a 59-year-old gentleman presented with
recurrent near syncope preceded by fast palpitation.
Echocardiographic examination showed normal left and
right ventricles. Holter study showed regular wide
complex tachycardia with rate of 200/min during his
symptoms. Cardiac catheterization and cineangiography
showed normal coronary arteries, left and right
ventricles. Programmed electrical stimulation (PES)
was able to induce clinical arrhythmia of cycle length
250 ms with left bundle branch block (LBBB) pattern
and inferior axis by 3 ventricular stimuli suggesting
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RVOT VT. His blood pressure dropped to 80/40 mmHg
during tachycardia with marked dizziness. Overdrive
pacing with cycle length 200 ms was successful in
terminating the arrhythmia. There was breakthrough
palpitation attack despite antiarrhythmic therapy. The
patient preferred ablative therapy for his drug-resistant
arrhythmia. Third patient was a 32-year-old lady with
symptomatic VE. Frequent VE and non-sustained VT
are detected in Holter study with 12% of total QRS
complex due to VE. Echocardiographic examination
showed slightly enlarged RV and normal LV function.
Magnetic resonance imaging confirmed fatty
replacement of RV free wall suggestive of
arrhythmogenic RV dysplasia. She had no history of
syncope. Her VE had LBBB pattern with inferior axis
again suggesting RVOT in origin. She was treated by
various antiarrhythmic drugs but all failed to control
her symptoms. She agreed for ablation therapy.

were performed under local anaesthesia. Standard
diagnostic electrophysiological catheters were
positioned conventionally in the heart via right femoral
vein under fluoroscopic guidance. The Ensite noncontact catheters were positioned inside the selected
cardiac chamber via left femoral vein. In the patient
with focal right AT, the Ensite catheter was advanced
to right atrium (Figure 1) with guide wire lined up from
inferior vena cava (IVC) to superior vena cava (SVC).
In the patient with right ventricular outflow tract
ventricular tachycardia and symptomatic ventricular
ectopics, the Ensite catheter was positioned in the RVOT
(Figure 2) with guide wire lined up from RVOT to
pulmonary artery across pulmonary valve (PV).
Intravenous heparin was given to maintain activation
clotting time between 300-400 seconds throughout the
procedure in a half-hour blood-sampling interval.

Creation of Chamber Geometry and Isopotential
Map Generation

Methods
All 3 patients gave written consents before the
procedures. All antiarrhythmic drugs were stopped for
at least 5 half-lives before the procedures. The procedures

To create chamber geometry and generate the
isopotential map, the non-contact Ensite catheter and a
standard roving catheter were positioned in the cardiac
chamber of interest. A 5.68 kHz (range of audible
frequency: 0.02-20 kHz) signal was emitted from the

Figure 1. Left Panel. Right Anterior Oblique View. Right Panel. Left Anterior Oblique View. X-rays of patient with focal right
atrial tachycardia with Ensite Catheter (EC) in-situ. ABL=Ablation catheter.
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Figure 2. Right Panel. Anteroposterior view, and Left Panel. Lateral view. X-rays of the patient with ARVD and symptomatic
ventricular ectopics with Ensite Catheter (EC) in-situ. ABL=ablation catheter.

electrode tip of the roving catheter that was in contact
with the endocardial surface. Good contact of the roving
catheter to the endocardial surface was confirmed by
bipolar intracardiac signal detected by the roving
catheter. By manipulating the roving catheter along the
endocardial surface of the chamber, the strength of the
signal was continuously recorded at each of the 64 array
electrodes over the Ensite catheter. Data are sampled at
1.2 kHz and filtered with a programmable bandwidth
between 0.1 and 300 Hz. From these recorded potentials,
the electrophysiological data of the roving catheter in
relation to the Ensite catheter could be computed by
the boundary element method. This method (Appendix
I) uses an inverse formulation to solve Laplace's
equation for each sample, yielding endocardial
potentials or virtual electrograms and thus creating the
isopotential map of the chamber. With this method,
location of the roving catheter tip in relation to the Ensite
catheter can also be computed. Sampling of the location
of the roving catheter occurred at the diastolic phase of
cardiac cycle. The system automatically stores only the
most distant points visited by the roving catheter in order
to ignore those detected when the catheter is not in
contact with the endocardial wall. With all the sampled
locations, the chamber geometry could then be
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established. The sampled locations were put into a
convex hull algorithm to build a faceted model. Using
a bicubic-spline smoothing algorithm, the convex model
is converted into a high-resolution contoured model of
the chamber. By combining the location and endocardial
potential data, the patient-specific electroanatomic
information of the cardiac chamber could be displayed.
With advanced computer graphics, the chamber model
could be rotated in any projection to facilitate
understanding of activation sequences. The isopotential
mapping was displayed in a colour-coded format. After
completing the chamber geometry and isopotential map,
the roving catheter could be removed from the chamber.
While the Ensite non-contact catheter is in the fixed
position inside the cardiac chamber, the changes of
endocardial potential by activation sequences during
arrhythmia could be recorded for analysis.

Arrhythmia Identification and Ablation
Navigation
With induction of clinical arrhythmia, the
activation of the arrhythmia could be displayed in the
three-dimensional contour of the cardiac chamber. Full
chamber vision allowed us to rapidly elucidate the
characteristics of the arrhythmia e.g. reentrant circuit,
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focal tachycardia or common pathway and exit points.
Moreover, by means of locator property of the standard
roving catheter, the system would offer a navigational
guide to the ablation catheter to area of interest.

Results
Successful end-point of the procedure was
defined as non-inducibility of clinical arrhythmia with
and without isoproterenol. The procedures were
successful in all three patients. The procedure time
varied from 2.5 to 5.0 hours. The mean time in
establishing chamber geometry was 15.0 minutes.
Fluoroscopy time varied from 12.6 to 35.0 minutes. No
complication was encountered.

Patient with Focal Right Atrial Tachycardia
EPS showed no VA conduction. Programmed
electrical stimulation (PES) was unable to induce

clinical arrhythmia. With isoproterenol infusion,
frequent supraventricular ectopics were noted with right
atrial signal earlier than that of coronary sinus
suggesting right atrial ectopic beats. Atrial burst pacing
with cycle length 320 ms was able to induce sustained
arrhythmia of cycle length 360 ms with earliest atrial
activation at high right atrium. Injection of ATP to
induce AV block failed to terminate the atrial
arrhythmia. Mapping of the sinus beat versus
supraventricular ectopics confirmed earliest activation
of the ectopic beat originated from posterior wall of
right atrium. With initiation of arrhythmia, the earliest
site of activation was identified at the same spot as the
ectopic beat suggesting focal nature of the clinical
arrhythmia. The sequence of atrial activation during
focal atrial tachycardia was depicted in Figure 3 with a
10 ms time frame. No reentry circuit was detected during
the atrial tachycardia. The total atrial activation time
was 80 ms which was much shorter than the tachycardia
cycle length. Radiofrequency (RF) energy was delivered

Figure 3. Activation sequences of the patient with focal right atrial tachycardia in LAO projection. White patch denoted
the depolarization wavefront from 0 to 50 ms.

J HK Coll Cardiol, Vol 9

October 2001

161

THREE-DIMENSIONAL NON-CONTACT ENDOCARDIAL ACTIVATION MAPPING

to the right atrial focus during tachycardia. Tachycardia
was terminated and sinus rhythm resumed 5 seconds
after the onset of RF application. Total number of RF
ablation was two. The atrial tachycardia was not
inducible by burst pacing or PES with and without
isoproterenol infusion. At 2-month follow up, the patient
had no recurrence of atrial arrhythmia.

Patient with Haemodynamically Unstable
RVOT VT
With positioning of Ensite catheter to RVOT,
geometry of RVOT was established with location of
pulmonary valves, His bundle, RV apex and tricuspid
annulus. VT was induced again by PES with concurrent
non-contact activation mapping. Significant haemodynamic compromise was again detected and required
emergency termination of arrhythmia by overdrive
pacing. Activation mapping information during the

period of VT was recorded for off-line analysis. Earliest
focus of activation during VT was located and marked
at lateral wall of RVOT below PV, as shown in the threedimensional display in Figure 4. With the Ensite
navigational guide, roving catheter was manipulated to
the earliest focus as marked in the three-dimensional
display. RF energy was delivered via the roving catheter
to the target focus during sinus rhythm. The total number
of RF ablation was five. PES and burst pacing was
unable to induce VT with and without isoproterenol
infusion after ablation. Antiarrhythmic drugs were
stopped and there was no recurrence of VT at 2-month
after the procedure.

Patient with Symptomatic Ventricular Ectopics
The Ensite catheter was positioned to the RVOT
(Figure 2) as in the last patient. There was no sustained
VT inducible by PES with and without isoproterenol.

Figure 4. Activation sequences of the patient with RVOT VT in lateral projection. White patch denotes the depolarization
wavefront from 0 to 60 ms. The earliest site of activation was located at lateral wall of RVOT just below the pulmonary valve
(the dark continuous line at top part of the RVOT model). Radiofrequency ablation was delivered to the white patch area
shown in the 2 ms time frame.
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Frequent VE was noted. Non-contact mapping of the
VE showed the earliest site of activation of these VE
come from posterolateral wall of RVOT below the PV.
RF energy was delivered to the focus of earliest
activation of the VE. Multiple RF ablations around the
focus were required to suppress VE. The total number
of RF ablations was 12. PES and pacing with and
without isoproterenol failed to induce VE or nonsustained VT. Repeated Holter study showed marked
reduction of VE to less than 1% of total QRS complexes
and marked symptomatic improvement as reported by
patient after RF ablation.

Discussion
These three cases well illustrated that the noncontact endocardial activation mapping system could
greatly enhance the understanding of arrhythmia
activation and facilitate mapping in patients with
haemodynamically unstable or non-sustained
arrhythmia. Conventional activation mapping in patients
with atrial tachycardia is a prolonged procedure with
significant fluoroscopic exposure. In our patient, the
actual time spent between initiation and termination of
arrhythmia by RFA was less than 1 hour reflecting the
effectiveness of the mapping system and the
navigational guide in positioning the ablation catheter.
Moreover, in patient with haemodynamically unstable
VT, activation mapping by conventional method would
be almost impossible. The Ensite system provided a
record-and-review off-line analysis of the activation
mapping during the few beats of unstable VT. This
unique feature enables one to apply activation mapping
in ablation of VT in ischaemic heart disease. Single beat
mapping with the Ensite system permits short-duration
but high-resolution mapping of the ectopic beat, as
illustrated in the last patient. With regards to using
ablative therapy for symptomatic ventricular ectopics
in the third patient, it has to be emphasized that this is
not a first line standard therapy for this condition. Lee
et al. reported that ablation for symptomatic frequent
VE was associated with high rate of cure and
improvement in the quality of life and appeared superior
to drug therapy.11-12 Two antiarrhythmic drugs had been
tried but both failed to control her symptoms. Therefore,
such non-conventional ablative therapy was suggested
and accepted by the patient. The apparently higher
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number of RF applications in the last patient may be
related to the diseased and fibrotic tissue in the affected
right ventricle. Whether it is related to the accuracy of
the mapping system requires further research and
mapping experience in patients with ARVD, especially
comparing to conventional catheter-based methods.
However, the non-contact mapping should not be
considered as a substitute for the conventional methods.
The three cases discussed could well be managed by
conventional methods. Whether the postulated benefit
of shorter procedure time, less fluoroscopic exposure
and guiding ablation for non-sustained or unstable
arrhythmia by the non-contact system requires
randomized comparison with the conventional methods
in the future.

Comparison of the Ensite System with other
Catheter-Based Mapping System
Conventionally increasing the number of
electrodes to a single contact catheter or putting multiple
catheters inside the chamber of interest for activation
mapping had been advocated but with obvious
limitations. Even using catheters with different shapes,
the entire endocardial surface activation could not be
analyzed simultaneously.7,8 Moreover, the multiple
catheters may hinder the positioning of ablation catheter
to the specific site of interest.
Pace mapping may be an alternative mapping
method for unstable arrhythmia. By positioning a
catheter at a specific point, pacing via the catheter tip
to acquire 12-lead matched ECG to look for focus of
interest has been used to map unstable VT. However,
identical pace maps can be observed up to 8 mm from a
tachycardia focus. 9 Precision of pace mapping is a
limitation.
With a special catheter containing a magnetic
field sensor along with a magnetic field emitter located
beneath the patient table (CARTO system), Gepstein et
al. created a three-dimensional electroanatomical
mapping of a cardiac chamber.10 However, this system
requires serial mapping of endocardial sites with a
contact catheter. Therefore, this system may not be
useful for mapping VT associated with haemodynamic
instability.

Limitation of the Ensite System
There are 3 major limitations of the Ensite
System. In vitro testing, the accuracy of computed

October 2001

163

THREE-DIMENSIONAL NON-CONTACT ENDOCARDIAL ACTIVATION MAPPING

electrograms deteriorated significantly when the
distance between the array to the endocardial surface is
more than 50 mm, thus creating difficulty in mapping
of severely enlarged chamber or remote site from the
catheter.3 Second limitation is in patients with ischaemic
VT utilizing epicardium as part of the circuit. As the
system has assumed endocardial surface depolarization,
epicardial reentry circuit may not be clearly delineated
by such mapping system.5 This non-contact mapping
system assumed that the geometry of the chamber had
no significant difference between during sinus rhythm
and tachycardia. In vigorously contracting chamber
during tachycardia, theoretically, the geometry of the
chamber may be distorted and affect the accuracy of
the computed geometry. However, the relatively high
success rate of ablative therapy using this mapping
system may indicate that this theoretical error may
actually be negligible.5 One of the major concerns of
using this system is the cost, especially comparing to
conventional methods. To our knowledge, there is no
data regarding cost-effective analysis of this system
comparing to conventional method. However, when
performing the analysis, factors like procedure time,
fluoroscopic exposure and application of the system in
selected patients with haemodynamically significant or
non-sustained arrhythmia should be taken into account.

Conclusion
Our data support the early experience with the
non-contact endocardial activation mapping system in
guiding successful ablation. Better understanding of
arrhythmia substrate can also be provided by this
mapping system. The application of this mapping
technique may enable one to tackle non-sustained
arrhythmia or complex arrhythmia associated with
haemodynamic instability.
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Appendix I
The electrical activity detected by the electrodes on the surface of the Ensite catheter is generated by the
potential field on the endocardial surface. Cavitary electrograms detected by the non-contact electrodes are of
lower amplitude and frequency than the source potentials on the endocardium, which limits their clinical
utility. A technique to enhance and resolve the actual endocardial surface potentials has been devised on an
inverse solution to Laplace's equation using a boundary element method, yielding endocardial potentials or
virtual electrograms.
The potential distribution on the Ensite catheter created by endocardial activation is described by Laplace's
equation. The potential field at any one electrode is influenced by the potentials from the entire endocardium,
with the degree of influence diminishing with the distance between the electrode and each endocardial point.
With this information, it is possible to compute endocardial electrograms from the potentials detected on the
Ensite catheter surface by an inverse solution of Laplace's equation.
This inverse solution is based on following formula:

∫∫ϑD vϑw/ϑn - wϑv/ϑndA = ∫∫∫D v∇ 2w-w∇ 2vdD
where D is a domain (the blood pool), ϑD is the boundary of D (the endocardium plus the Ensite balloon),
ϑ/ϑn represents the outward normal on D, ∇ 2 is the Laplacian, dA is the surface area differential and dD is the
volume differential, w is the potential field created by a unit charge in free space, and v is the potential field in
the domain. This equation is using the boundary element method, which is a numerical approach to solving
integral equations such as those governing the behaviour of electric fields in volume conductors.
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